News
-
-
COMMUNIQUÉ DE PRESSE
Aston Bay Signs Definitive Agreement to Option the Epworth Sediment Hosted Copper-Silver-Zinc-Cobalt Project, Nunavut, Canada; Dr. Elizabeth Turner Joins Advisory Board
Aston Bay Holdings Ltd. enters agreement to acquire 80% interest in property with high-grade copper mineralization in Nunavut, Canada. Dr. Elizabeth Turner joins Technical Advisory Board -
COMMUNIQUÉ DE PRESSE
Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve(R) Pivotal Trial to be Presented Today at the 46th Annual Charing Cross Symposium
enVVeno Medical presents positive efficacy data on VenoValve from SAVVE U.S. pivotal trial at Charing Cross International Symposium, showing clinical improvement for severe CVI patients -
-
COMMUNIQUÉ DE PRESSE
Tryp Therapeutics Provides Update on Plan of Arrangement With Exopharm Limited and Announces Voluntary Trading Halt
Tryp Therapeutics, Inc. announces shareholder approval and completion of plan of arrangement with Exopharm Limited. Anticipates trading on ASX as Tryptamine Therapeutics Limited (ticker symbol TYP) in May 2024 -
-
-
-
-
COMMUNIQUÉ DE PRESSE
TVM Capital Healthcare Announces EUR 16 Million Investment into neurocare
TVM Capital Healthcare invests EUR 16 million in neurocare group AG to support growth plans, including MENA region expansion. neurocare offers personalized mental health care with innovative neurostimulation methods and digital therapy platform
